Physician profile
Alex Nguyen
NPI 1528001930
$799.60
in general payments reported to CMS, 2019-2025
19 companies · $137 in 2025
The $137 reported for 2025 was less than what a typical Internal Medicine provider received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $523 · 2021: $27.10 · 2022: $27.69 · 2024: $84.39 · 2025: $137.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $222.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $221.70 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Janssen Biotech, INC. | $118.68 | 2019 | |
| Novo Nordisk INC | $106.07 | 2019-2024 | Rybelsus, Ozempic |
| Varian Medical Systems, INC. | $70.55 | 2019 | |
| Glaxosmithkline, LLC. | $65.35 | 2019-2024 | Shingrix, Arexvy |
| Amgen INC. | $61.46 | 2019-2025 | Krystexxa, Repatha, Otezla |
| Lilly USA, LLC | $47.57 | 2019-2025 | Mounjaro, Trulicity, Jardiance |
| Astrazeneca Pharmaceuticals LP | $46.35 | 2019-2024 | Farxiga |
| Mannkind Corporation | $43.30 | 2019 | |
| Dexcom, INC. | $40.66 | 2025 | Dexcom G6 Transmitter |
| Astellas Pharma US INC | $30.58 | 2019-2021 | |
| Amarin Pharma, INC. | $27.90 | 2019 | |
| Pfizer INC. | $27.69 | 2022 | |
| Seqirus USA INC | $22.02 | 2025 | Fluad, Flucelvax |
| Corcept Therapeutics | $20.28 | 2025 | Korlym |
| Boehringer Ingelheim Pharmaceuticals, INC. | $17.74 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exact Sciences Corporation | $17.54 | 2025 | Cologuard Collection Kit |
| Janssen Pharmaceuticals, INC | $14.94 | 2019 | |
| Optinose US, INC. | $13.78 | 2019 | |
| Fx Shoulder Solutions, INC | $7.14 | 2025 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Alex Nguyen listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.